1. Home
  2. CYD vs MBX Comparison

CYD vs MBX Comparison

Compare CYD & MBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYD
  • MBX
  • Stock Information
  • Founded
  • CYD 1951
  • MBX 36
  • Country
  • CYD Singapore
  • MBX United States
  • Employees
  • CYD N/A
  • MBX N/A
  • Industry
  • CYD Industrial Machinery/Components
  • MBX
  • Sector
  • CYD Industrials
  • MBX
  • Exchange
  • CYD Nasdaq
  • MBX NYSE
  • Market Cap
  • CYD 401.8M
  • MBX 347.9M
  • IPO Year
  • CYD 1994
  • MBX 2024
  • Fundamental
  • Price
  • CYD $20.00
  • MBX $10.88
  • Analyst Decision
  • CYD
  • MBX Strong Buy
  • Analyst Count
  • CYD 0
  • MBX 4
  • Target Price
  • CYD N/A
  • MBX $37.25
  • AVG Volume (30 Days)
  • CYD 231.0K
  • MBX 319.2K
  • Earning Date
  • CYD 02-25-2025
  • MBX 03-07-2025
  • Dividend Yield
  • CYD 1.90%
  • MBX N/A
  • EPS Growth
  • CYD 14.53
  • MBX N/A
  • EPS
  • CYD 1.17
  • MBX N/A
  • Revenue
  • CYD $2,639,608,357.00
  • MBX N/A
  • Revenue This Year
  • CYD $11.68
  • MBX N/A
  • Revenue Next Year
  • CYD $4.06
  • MBX N/A
  • P/E Ratio
  • CYD $17.10
  • MBX N/A
  • Revenue Growth
  • CYD 15.32
  • MBX N/A
  • 52 Week Low
  • CYD $7.95
  • MBX $8.63
  • 52 Week High
  • CYD $23.22
  • MBX $27.50
  • Technical
  • Relative Strength Index (RSI)
  • CYD 88.37
  • MBX N/A
  • Support Level
  • CYD $11.16
  • MBX N/A
  • Resistance Level
  • CYD $23.22
  • MBX N/A
  • Average True Range (ATR)
  • CYD 1.31
  • MBX 0.00
  • MACD
  • CYD 0.89
  • MBX 0.00
  • Stochastic Oscillator
  • CYD 75.08
  • MBX 0.00

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International primarily operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About MBX MBX BIOSCIENCES INC

MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.

Share on Social Networks: